What is ESOCHILL used for?

ESOCHILL is an injection used to treat severe Acidity / GERD / Indigestion by reducing the amount of acid produced in the stomach.

Can I take ESOCHILL at home?

No, ESOCHILL is an injectable medication that must be administered by a qualified healthcare professional in a clinical setting.

How long does ESOCHILL take to work?

As an intravenous injection, ESOCHILL begins to work almost immediately to suppress gastric acid secretion.

ESOCHILL

Generic Salt Composition: ESOMEPRAZOLE 40MG INJ

Price: ₹135 MRP: ₹135

Save up to 0% compared to branded medicines.

Top Brand Substitutes & Equivalents

Nexpro IV, Esomac IV, Sompraz IV, Esofag IV, Razo IV, Esoz IV, Izra IV, Esopride IV, Esogress IV, Esolok IV, Zes IV, Esotop IV, Esopump IV, Esoprax IV, Esocip IV, Esomep IV, Esotrol IV, Esomax IV, Esopure IV, Esotab IV, ESOMEPRAZOLE Sun Pharma, Sun Pharma ESOMEPRAZOLE, ESOMEPRAZOLE Cipla, Cipla ESOMEPRAZOLE, ESOMEPRAZOLE Dr Reddys, Dr Reddys ESOMEPRAZOLE, ESOMEPRAZOLE Lupin, Lupin ESOMEPRAZOLE, ESOMEPRAZOLE Torrent, Torrent ESOMEPRAZOLE

Product Overview & Uses

ESOCHILL is a high-efficacy proton pump inhibitor (PPI) formulated as a 40mg injection. It is primarily utilized in the clinical management of conditions related to excessive gastric acid production, falling under the category of Acidity / GERD / Indigestion. By targeting the final step of acid production in the stomach, ESOCHILL provides rapid and sustained relief from symptoms associated with gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. In hospital environments, ESOCHILL is often the preferred choice for patients who cannot swallow tablets or require immediate therapeutic intervention for acute gastric distress. The administration of ESOCHILL ensures that gastric pH levels are elevated, which promotes the healing of mucosal lesions and prevents further acid-related complications. As a specialized treatment for Acidity / GERD / Indigestion, ESOCHILL is strictly administered by healthcare professionals to ensure safety and efficacy. Patients receiving ESOCHILL should be monitored for potential electrolyte imbalances or other systemic reactions associated with long-term PPI therapy.